PLT012 is a first-in-class anti-CD36 monoclonal antibody and the first metabolic checkpoint therapy designed to reprogram the tumor microenvironment Phase 1 trial expected to begin in 1Q 2026 DOVER, ...

Discord has launched its own annual user recap called Discord Checkpoint, similar to Spotify Wrapped. The feature summarizes a user's 2025 activity, including messages sent, time in voice chat, and ...

DEKALB COUNTY, Ga. — A TikTok video circulating widely on social media is raising new concerns about immigration enforcement in metro Atlanta. Text written in Spanish on the video translates to ...

Third time’s the charm? Microsoft hopes the scalability of Azure HorizonDB, will lure new customers where its two existing PostgreSQL databases did not. Microsoft is previewing a third ...

I am testing disaster recovery. I use the invoke backup mechanism to get two file, one representing the database backup (default-server.com-2025-11-05-230057.psql.bin.gz) and one representing the ...

The flag's no use sitting in your inventory - it needs to be placed on the ground to be activated. You can place it anywhere relatively flat, but we recommend you pick somewhere that's definitely safe ...

Umama Ali spent more time as a kid arguing with his brother over who caused the most chaos in GTA Vice City than doing homework, and he’s been unapologetically hooked on games ever since. That ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

A research team at Lund University in Sweden has discovered a mechanism that helps acute myeloid leukemia cells to evade the body's immune system. By developing an antibody that blocks the mechanism, ...

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. By submitting this information, I agree to the privacy policy and to learn more about ...

Company to deliver oral and poster presentations for data on leronlimab’s action on PD-L1 expression and patient survival in triple-negative breast cancer VANCOUVER, Washington, Sept. 25, 2025 (GLOBE ...